Skip to main content

Peer Review reports

From: The effect of decitabine-combined minimally myelosuppressive regimen bridged allo-HSCT on the outcomes of pediatric MDS from 10 years’ experience of a single center

Original Submission
29 Sep 2021 Submitted Original manuscript
21 Dec 2021 Reviewed Reviewer Report
3 Feb 2022 Reviewed Reviewer Report
24 Feb 2022 Author responded Author comments - Shaoyan Hu
Resubmission - Version 2
24 Feb 2022 Submitted Manuscript version 2
25 Feb 2022 Author responded Author comments - Shaoyan Hu
Resubmission - Version 3
25 Feb 2022 Submitted Manuscript version 3
20 Mar 2022 Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
19 May 2022 Editorially accepted
27 May 2022 Article published 10.1186/s12887-022-03376-1

You can find further information about peer review here.

Back to article page